School of Medicine

Researchers at WashU Medicine have harnessed the internal circadian clock of the body to deliver medication for an inflammatory illness precisely when it was most needed.

Aaron Y. Lee, MD, a leader in applying artificial intelligence to ophthalmology research and patient care, will head the John. F. Hardesty, MD, Department of Ophthalmology & Visual Sciences at WashU Medicine.

A clinical trial led by Richard S. Hotchkiss, MD, a professor of anesthesiology at WashU Medicine, has found that treating critically ill COVID-19 patients with an immune-boosting protein reduces life-threatening secondary infections, a major cause of death in such patients.

A blood test for Alzheimer’s disease developed by researchers at WashU Medicine and Lund University not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed.

Steven Bassnett, a national leader in vision research, has been installed as the inaugural Grace Nelson Lacy Distinguished Professor in Ophthalmology at WashU Medicine.

Julian Fleischman, an associate professor emeritus of molecular microbiology at Washington University School of Medicine, died Jan. 18 at his home in Sharon, Mass., from complications following a fall. He was 91.

Seven WashU faculty members are among the 471 new fellows selected by the American Association for the Advancement of Science.

The National Institutes of Health (NIH) is supporting a WashU Medicine effort to track neuroinflammation in the brains of patients with Parkinson’s disease.

Researchers at WashU Medicine have found a way to target the vessels that drain waste from the brain. Rejuvenating those vessels could open the door to new therapies to prevent cognitive decline.

A clinical trial among people destined to develop early-onset Alzheimer’s disease and led by WashU Medicine researchers shows eliminating amyloid from the brain may prevent cognitive symptoms.